Browsing byAuthorZang, Dae Young

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 5 to 12 of 12

Issue DateTitleAuthor(s)Type
2016Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study문영철Article
2009Induction Therapy with "3+7" Chemotherapy Plus ATRA Followed by Consolidations with Three Courses of Idarubicin Alone and Maintenance Therapy with ATRA in Newly Diagnosed Acute Promyelocytic Leukemia (APL) Has An Excellent Leukemia-Free Survival but Minimal Toxicity in Low and Intermediate Risk Groups성주명; 문영철Meeting Abstract
2020Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)문영철Article
2022Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia성주명; 문영철; 김대영; 박영훈Article
2015Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib문영철Meeting Abstract
2009Randomized, Multicenter, Phase III Trial of Heptaplatin 1-hour Infusion and 5-Fluorouracil Combination Chemotherapy Comparing with Cisplatin and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer이순남Article
2012Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or -intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party성주명Meeting Abstract
2012TREATMENT OUTCOMES OF GEMCITABINE VERSUS GEMCITABINE PLUS PLATINUM FOR BILIARY TRACT CANCER: A KOREAN CANCER STUDY GROUP RETROSPECTIVE ANALYSIS남은미Meeting Abstract

BROWSE